Natera, Inc. (NTRA) Dividend History

Natera, Inc. is a biotechnology company specializing in genetic testing and diagnostics. It develops and offers advanced cell-free DNA testing services for reproductive health, oncology, organ transplant monitoring, and rare disorders. Natera's innovative approach includes non-invasive prenatal testing (NIPT) and other laboratory-based genetic assays to help clinicians and patients make informed medical decisions.

13011 Mccallen Pass, Austin, TX, 78753
Phone: 650-249-9090
Website: https://www.natera.com

Dividend History

Natera, Inc. currently does not pay dividends

Company News

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

The Minimal Residual Disease (MRD) Testing Market is expected to grow at a CAGR of 11.18% from 2025 to 2030, driven by advancements in diagnostic technologies and the increasing focus on precision medicine and early relapse detection.

GlobeNewswire Inc.

Featured Companies: ADPT AMGN BIO BIO.B BMY DGX EXAS GH GILD ILMN LH MDXH MYGN NEO OPK TECH VCYT
Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™.

The global Liquid Biopsy Market is expected to grow at a CAGR of 11.9%, reaching $11.3 billion by 2029. The increasing burden of cancer and the advantages of liquid biopsy over traditional methods are driving the market growth.

GlobeNewswire Inc.

Featured Companies: BIO BIO.B EXAS GH ILMN MYGN QGEN TMO
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings

Stanley Druckenmiller's Duquesne Family Office investment vehicle has been concentrating its capital in a diverse mix of growth stocks and established businesses with substantial revenue opportunities, including Natera, Coupang, Coherent, Woodward, and Seagate Technology.

The Motley Fool

Featured Companies: COHR CPNG STX WWD
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings

Stanley Druckenmiller, a renowned investor, has made significant investments in several companies, including Natera, Coupang, Coherent, Woodward, and Seagate Technology. The article analyzes Druckenmiller's portfolio moves and provides insights into his investment strategy.

The Motley Fool

Featured Companies: COHR CPNG STX WWD
Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights

The liquid biopsy market is experiencing significant growth, driven by advancements in technology and increasing demand for non-invasive diagnostic methods. North America is the largest market, with a 48.11% share in 2023. Key drivers include increased benefits over conventional biopsy, rising cancer incidence, and technological advancements, while high costs and shortage of skilled professionals pose challenges.

GlobeNewswire Inc.

Featured Companies: BIO BIO.B CDNA EXAS GH ILMN MDXH MYGN QGEN TMO

Dividend data last updated 06/07/2025 14:57:41 UTC